Hepatocyte growth factor protects human embryonic stem cell derived-neural progenitors from hydrogen peroxide-induced apoptosis.

Zhi-Xing Hu,Ju-min Geng,Dao-ming Liang,Min Luo,Ma-Lin Li
DOI: https://doi.org/10.1016/j.ejphar.2010.07.011
IF: 5.195
2010-01-01
European Journal of Pharmacology
Abstract:Promoting human embryonic stem cell (hESC)-derived-neural progenitor survival in the pro-apoptotic niche is pivotal for stem cell replacement therapy. The present study was designed to investigate the protective effect of hepatocyte growth factor (HGF) on hESC-derived neural progenitor injured by hydrogen peroxide (H2O2) exposure. Treatment of hESC-derived neural progenitor cells with HGF prior to H2O2 exposure conferred protective effect against oxidative stress-induced apoptosis. HGF treatment increased both phosphoinositide 3-kinase (PI3K)/Akt and extracellular signal-regulated kinase1/2 (ERK1/2) phosphorylation. However, selective inhibition of each pathway supported that the activation of PI3K/AKT, but not ERK1/2, provides survival advantage to the neural progenitor cells. Further investigation indicated that HGF pretreatment could attenuate the decrease of the expression of Bcl-2 protein induced by H2O2, whereas the level of Bax was not affected. Additionally, we observed that H2O2-induced decrease of mitochondrial transmembrane potential, release of cytochrome c and increase of caspase-3 activation were alleviated by HGF pretreatment. These effects of HGF could be reversed by inhibition of the PI3K/Akt and ERKs pathways, indicating PI3K/Akt and ERKs signaling might be involved in HGF-mediated regulation of mitochondrial apoptotic pathway mediated by H2O2. The neuroprotective effect of HGF might potentially be useful in stem cell-based therapies for neurodegenerative disorders.
What problem does this paper attempt to address?